C12Y 304/17001
Carboxypeptidase a
Official title: Carboxypeptidase A (3.4.17.1)
C12Y304/17001 (Carboxypeptidase a) appears on 10 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 10
- Published applications
- 10
- Assignees
- 14
- Inventors
- 35
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 2 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 1 | 0 |
| 2025 | 0 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Hydrolyzed collagen for use in reducing blood glucose26 May 2026US 12,636,339 B2Rousselot B.V.
- Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors27 Aug 2024US 12,070,460 B2Regeneron Pharmaceuticals, Inc.
- Method for enzymatically preparing peptides for use in improvement of brain function20 Dec 2016US 9,523,109 B2Calpis Co., Ltd.
- Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma8 Jul 2014US 8,771,691 B2Inserm (Institut National De La Sante Et De La Recherche Medicale)
- Carboxypeptidases and nucleic acids encoding same15 Aug 2006US 7,091,002 B2Novozymes A/S
- Hydrolyzed collagen for use in reducing blood glucose27 Aug 2026US 2026/0248875 A1Rousselot B.V.
- Hydrolyzed collagen for use in reducing blood glucose5 Jun 2025US 2025/0177472 A1Rousselot B.V.
- Methods Of Treating Skin Cancer With Carboxypeptidase Vitellogenic Like (CPVL) Inhibitors16 Jan 2025US 2025/0017929 A1Regeneron Pharmaceuticals, Inc.
- Improved process for the separation and analysis of pancreatic enzymes28 Sep 2023US 2023/0303621 A1
- Methods Of Treating Skin Cancer With Carboxypeptidase Vitellogenic Like (CPVL) Inhibitors9 Feb 2023US 2023/0037524 A1Regeneron Pharmaceuticals, Inc.
Most cited
By later US patents
- Method for preparing cheese flavor concentrate35US 4,708,876 AFuji Oil Company, Limited · 1987
- Method of obtaining protein hydrolysates16US 6,036,983 ANovo Nordisk A/S · 2000
- Protein hydrolysates produced with the use of cod proteases10US 7,070,953 B1Nordur EHF · 2006
- Process for producing seasoning8US 4,684,527 AKikkoman Corporation · 1987
- Carboxypeptidases and nucleic acids encoding the same4US 6,187,578 B1Novo Nordisk A/S · 2001